SMTL ID : 7lty.1

Bruton's tyrosine kinase in complex with compound 23

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x YD7: ~{N}-[(5~{R})-2-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-5-yl]-3-propan-2-yloxy-azetidine-1-carboxamide(Non-covalent)

YD7.1: 18 residues within 4Å: Chain A: L.16, G.17, T.18, G.19, F.21, V.24, A.36, K.38, E.83, Y.84, M.85, A.86, G.88, N.134, L.136, D.147, S.151, V.154 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.24, A:V.24, A:V.24, A:A.36, A:L.136, A:V.154 Hydrogen bonds: A:M.85, A:M.85 Water bridges: A:G.19

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 4 residues within 4Å: Chain A: R.170, M.204, E.207, F.209 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hopkins, B.T. et al., Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis. J.Med.Chem. (2022)

Release Date

2022-01-12

Peptides

Isoform BTK-C of Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Isoform BTK-C of Tyrosine-protein kinase BTK

Related Entries With Identical Sequence